Neutralizing circulating ghrelin by expressing a growth hormone secretagogue receptor-based protein protects against high-fat diet-induced obesity in mice

A systematic review and mixed treatment comparison of pharmacological interventions for the treatment of obesity

(2012) L. J. Gray et al.   Obesity Reviews

The Gut Hormones PYY3-36 and GLP-17-36 amide Reduce Food Intake and Modulate Brain Activity in Appetite Centers in Humans

(2011) Akila De Silva et al.   Cell Metabolism

Health and economic burden of the projected obesity trends in the USA and the UK

(2011) Y Claire Wang et al.   LANCET

The role of inflammation and macrophage accumulation in the development of obesity-induced type 2 diabetes mellitus and the possible therapeutic effects of long-chain n-3 PUFA

(2010) Elizabeth Oliver et al.   PROCEEDINGS OF THE NUTRITION SOCIETY

Effects of Growth Hormone on Glucose, Lipid, and Protein Metabolism in Human Subjects

(2009) Niels Møller et al.   ENDOCRINE REVIEWS

Acylated and desacyl ghrelin stimulate lipid accumulation in human visceral adipocytes

(2009) A Rodríguez et al.   INTERNATIONAL JOURNAL OF OBESITY

Ghrelin Induces Abdominal Obesity Via GHS-R-Dependent Lipid Retention

(2009) Jeffrey S. Davies et al.   MOLECULAR ENDOCRINOLOGY

Gut hormones: Implications for the treatment of obesity

(2009) Marianne T. Neary et al.   PHARMACOLOGY & THERAPEUTICS

Ghrelin is a physiological regulator of insulin release in pancreatic islets and glucose homeostasis

(2008) Katsuya Dezaki et al.   PHARMACOLOGY & THERAPEUTICS

Visualization of ghrelin-producing neurons in the hypothalamic arcuate nucleus using ghrelin-EGFP transgenic mice

(2007) Haruaki Kageyama et al.   REGULATORY PEPTIDES